| Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India AC Mishra, VA Arankalle, SA Gadhave, PH Mahadik, S Shrivastava, ... PLoS neglected tropical diseases 12 (8), e0006657, 2018 | 28 | 2018 |
| Virus-host protein-protein interactions as molecular drug targets for arboviral infections M Bhutkar, V Singh, P Dhaka, S Tomar Frontiers in Virology 2, 959586, 2022 | 7 | 2022 |
| Infectivity and growth kinetics of Herpes Simplex Virus type-2 in MOLT4 CCR5+ and CEM CCR5+ T cell lines D Desai, M Bhutkar, S Kulkarni Microbial pathogenesis 123, 82-88, 2018 | 4 | 2018 |
| Elucidation of antiviral mechanisms of natural therapeutic molecules Herbacetin and Caffeic acid phenethyl ester against chikungunya and dengue virus M Bhutkar, R Rani, A Pathak, A Kothiala, S Mahajan, B Waghmode, ... bioRxiv, 2022.05. 31.494145, 2022 | 1 | 2022 |
| Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody V Singh, M Bhutkar, S Choudhary, S Nehul, R Kumar, J Singla, P Kumar, ... Biochemical and Biophysical Research Communications, 150746, 2024 | | 2024 |
| Viral methyltransferase inhibitors: berbamine, venetoclax, and ponatinib as efficacious antivirals against chikungunya virus ST Mandar Bhutkar , Ankita Saha Arch Biochem Biophys, 10.1016/j.abb.2024.110111, 2024 | | 2024 |
| Enhancing affinity of neutralizing SARS-CoV-2 nanobody through facile structure-guided mutations in CDRs V Singh, M Bhutkar, S Choudhary, S Nehul, R Kumar, J Singla, P Kumar, ... bioRxiv, 2024.05. 13.593833, 2024 | | 2024 |
| Therapeutic Antiviral Potential of Flavonoids R Rani, M Bhutkar, S Tomar Flavonoids as Nutraceuticals, 57-101, 2024 | | 2024 |
| Designing and bioengineering of CDRs with higher affinity against receptor-binding domain (RBD) of SARS-CoV-2 Omicron variant V Singh, S Choudhary, M Bhutkar, S Nehul, S Ali, J Singla, P Kumar, ... bioRxiv, 2024.09. 19.613860, 2024 | | 2024 |
